R&D in Dentistry:
Complexity is not Eligibility
High-level clinical skill is admirable, but it is rarely "Experimental Development" in the eyes of the tax law. Explore this interactive report to understand why honesty in eligibility assessment is the only safe path for dental practices.
The Misconception Matrix
Context:
Many dentists assume that difficult, complex casework qualifies for R&D. This chart visualizes the gap between Clinical Complexity and Technological Uncertainty.
The Activity Filter
Click an activity to test its eligibility against tax legislation.
Common Claims
Select an Activity
See how Swanson Reed evaluates potential claims to prevent audit risk.
The Cost of "Yes"
Some advisors will file any claim to get a fee. Swanson Reed takes a different approach. We believe that integrity is the best financial strategy.
Filing ineligible claims for standard dental work exposes practices to audits, penalties, and the repayment of credits with interest.
Why Swanson Reed?
"We do not sell dreams; we sell compliance."
Swanson Reed will candidly tell a dental practice if they do not qualify. We prioritize long-term reputation over short-term fees. If your work is standard clinical practice, we will not mislead you into filing a risky claim.
The Technical Framework for R&D Tax Credits in Specialized Dental Practices
Eligibility for federal and state R&D tax credits provides a critical dollar-for-dollar offset against taxes owed or paid, enabling businesses to significantly increase cash flow and reinvest in core innovation.1 While the credit is traditionally associated with heavy industry, software development, or pharmaceutical manufacturing, the statutory framework of Internal Revenue Code (IRC) § 41 extends eligibility to any business—including specialized dental practices—that engages in activities intended to invent or improve a business component, such as a process, technique, software, or formula.1 The value of the credit is tied directly to Qualified Research Expenses (QREs), including the wages of technical employees, the cost of supplies consumed in testing, and payments to contractors engaged in research efforts.1 A defensible R&D claim requires the simultaneous satisfaction of the rigorous IRS Four-Part Test.3 The first component, the Permitted Purpose Test, dictates that the activity must be aimed at creating a new or improved function, performance, reliability, or quality of the business component.3 For dentistry, this includes activities such as developing innovative prototypes for new dental appliances, inventing new tooling, or streamlining proprietary procedural processes.1 The second requirement, the Technological in Nature Test, mandates that the research must fundamentally rely on the principles of physical or computer sciences, engineering, or mathematics.3 Given that the IRS no longer requires the research to obtain knowledge exceeding the common knowledge of skilled professionals 4, the focus is on applying scientific methodology to resolve technical challenges. Since dental R&D often involves material science (e.g., optimizing composite adhesion) or engineering (e.g., new device design), specialized R&D advisors must employ multidisciplinary teams—including engineers and scientists alongside tax professionals 5—to accurately substantiate the necessary scientific foundation required by the statute, ensuring the claim is technically sound, not merely an accounting exercise.
The defining characteristic that separates qualifying R&D from routine clinical work rests on satisfying the final two parts of the statutory test. The third requirement, the Elimination of Uncertainty Test, demands that the research is undertaken specifically to discover information that resolves an uncertainty concerning the business component’s capability, design, or methodology.3 This is a crucial distinction: simply acquiring and implementing a new commercial technology, such as a 3D printer, does not qualify. However, developing new proprietary techniques or optimized procedures utilizing that technology, specifically to eliminate uncertainties regarding fit, accuracy, or material efficacy, does qualify.6 If such uncertainty exists, the final requirement, the Process of Experimentation Test, must be met.3 This necessitates a systematic investigation involving testing, modeling, simulation, or sequential trials to evaluate alternatives.7 This systematic process generates the required QREs, such as the wages of technical staff (dentists, lab staff) dedicated to experimentation and the costs of trial materials.1 Activities explicitly excluded from qualification include routine software development, customized configuration of existing technology, trivial changes, and bug fixing.8 Because the defensibility of the credit—which can reach 6% of QREs in early claim years 9—is intrinsically linked to proving both the existence of technical uncertainty and the systematic documentation of the experimentation process, inadequate substantiation of technical staff time is the paramount audit risk. Therefore, while innovation in ceramic layering or proprietary patient management software can be eligible, the failure to meticulously track the technical staff’s time spent resolving the uncertainty can lead to a total disallowance of the claimed credit.
The rationale behind a specialist firm’s commitment to honesty and refusal to file non-qualifying claims, such as that demonstrated by Swanson Reed, is fundamentally linked to institutional risk management and audit exposure. The firm’s commitment to being “one of the most, if not, the most conservative R&D tax providers in the market” 10 is codified through rigorous internal controls, including objective, third-party validation of its risk management policies via ISO 31000:2009 certification.10 This conservative methodology is operationalized through the mandatory, internal “Six-Eye Review,” where every claim must pass scrutiny by a qualified engineer, a scientist, and a CPA or Enrolled Agent.5 This rigorous gate ensures the claim is both technically sound and financially accurate before submission, maximizing its ability to withstand IRS scrutiny.10 Furthermore, this strict adherence to compliance is financially incentivized by the firm’s offer of financially backed audit protection.11 By absorbing the financial risk of defending claims, the firm aligns its profitability directly with compliance: accepting a claim that fails the statutory Four-Part Test or lacks robust documentation introduces a substantial, avoidable financial liability for the firm itself.11 Therefore, the systematic use of preliminary eligibility tools structured around the IRS Four-Part Test 3 and the final institutional review acts as a necessary fiduciary gate. The decision to reject a practice that does not genuinely meet the stringent technical criteria is not merely an ethical choice, but a critical institutional requirement for maintaining defensibility and minimizing the substantial financial risk inherent in audit defense.
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state










